theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Radiation Oncology

ASCO 2021   

Questions discussed in this category


How would you sequence 177LU-PSMA-617 with current therapies for men with mCRPC?
2 Answers available

What strategies have you found to be most effective in engaging PCPs in a primary-care or shared-care model of survivorship for pediatric and AYA patients who will receive ongoing care in their communities away from their primary oncology treatment site?
In follow up to @Jacqueline Casillas presentation at ASCO 2021 regarding models of survivorship care delivery for AYA patients. 
1 Answer available

In what scenario would you give consolidation chemotherapy after chemoradiation for stage 3 cervical cancer with a good response?
3 Answers available
10129101147112


Papers discussed in this category


J. Clin. Oncol., 2011 Mar 28
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.

BMC Cancer, 2017 Apr 28
Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy.

Related Topics in Radiation Oncology

  • Lung Cancer
  • Workload
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.